MannKind | 营业利润

Operating Profit 更改 日
Adma Biologics USD -11941000 20.63M 2023-12
Dynavax Technologies USD -8491000 13.61M 2023-12
Eli Lilly USD 2.39B 1.94B 2023-12
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Insmed USD -178272000 30.6M 2023-12
MannKind USD 7.86M 2.76M 2023-12
Novo Nordisk DKK 26.91B 3.03B 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Xencor USD -35009000 16.74M 2023-12



MannKind 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.